MiMedx

mimedx.com · Marietta, United States of America

MiMedx is a biopharmaceutical company that develops and commercializes regenerative biologics derived from human placental tissue to treat chronic wounds, burns, and musculoskeletal conditions. It supplies allograft products primarily to hospitals, wound care centers, and physicians, generating revenue through the sale of these regulated therapeutic products. The company focuses on evidence-based, minimally invasive treatments that support tissue repair and reduce healing times for patients with complex conditions.

Revenue
$320.0M
Employees
850
Founded
2008
Headquarters
Marietta, United States of America

What 20 Arbolus experts think of MiMedx

NPS scores are skewed toward high satisfaction, with the majority of users scoring at or above 8. Renewal intent is highest among high spenders and those with more than a year of use. Most experts report being fully or recently implemented, with only a minority unsure or in offboarding. Quantitative data reveals positive themes of stickiness, satisfaction, and ongoing platform engagement, particularly among hospital-based clinical decision makers.Overall Customer Sentiment: Positive

Who reviewed MiMedx

Total customers 20 19 current · 1 former
Reviews growth +16 in six months
Seniority of respondents
  • C-Suite 84% (17)
  • Director 11% (2)
  • Manager 5% (1)
Not specified Director NPS 10
Other Generalist C-Suite NPS 6
Other Generalist C-Suite NPS 7

Employer names and spend open once the report publishes.

Tell us when the MiMedx report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

10 Net Promoter Score, from 20 scored reviews
  • Promoters 6
  • Passives 10
  • Detractors 4

Cumulative NPS by month

+0 over 6 months
  • Dec 8
  • Jan 7
  • Mar 8
  • Apr 8
  • Jul 8
  • Aug 8

Net Promoter Score across 2 reviews, accumulated up to each month. Category median 28 across 2 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 40%
  • Will renew 2
  • Undecided 3
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 25% 4 answers
  • Director 100% 1 answer
  • 8.5/10 Average score from customers who will renew
  • 7.7/10 Average score from undecided customers

Top alternatives

Most weighed by MiMedx customers

For people who use MiMedx

Do you use MiMedx at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 20 customers of MiMedx have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.